84
22
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T5521 | Bropirimine | U-54461 | TLR |
Bropirimine (U-54461) (U-54461) is a biological response modifier that is thought to act through the induction of lymphokines. | |||
T4451 | Estramustine phosphate sodium | Ro 21-8837/001,Estramustine phosphate disodium | Apoptosis , Microtubule Associated |
Estramustine phosphate sodium (Ro 21-8837/001) is an antimicrotubule chemotherapy agent; arrests prostate cancer cells in the G2/M phase of the cell cycle. | |||
T27603 | INCB3619 | INCB-3619,INCB 3619 | Immunology/Inflammation related |
INCB3619 is a selective and potent inhibitor of ADAM with antitumour effects, inhibiting ADAM10, ADAM17, MMP12 and MMP15. | |||
T77732L | HFY-4A HCL (2094810-82-7 Free base) | ||
HFY-4A HCL is a novel HDAC inhibitor.HFY-4A HCL has antitumour activity and has shown antiproliferative activity in breast cancer cells. | |||
T67884 | β-catenin modulator IIa-661 | Wnt/beta-catenin | |
β-catenin modulator IIa-661 is a small molecule inhibitor of the Wnt pathway with antitumour activity. | |||
TNU0031 | 5-Hydroxyuridine | OHUrd | Nucleoside Antimetabolite/Analog |
5-Hydroxyuridine (OHUrd) is a purine nucleoside analogue with potential antitumour activity, showing cytotoxicity against human colon adenocarcinoma cell lines. | |||
T69644 | DUN73423 | RET-IN-21 | c-RET |
DUN73423 (RET-IN-21) is a potent tyrosine kinase (RET) inhibitor with antitumour activity for the study of cancer. | |||
T61428 | 4-PQBH | Others | |
4-PQBH is a potent Nur77-binding agent with antitumour activity.4-PQBH inhibits xenograft tumours through Nur77-mediated endoplasmic stress and autophagy by broadly inducing cysteoaspartase-independent cytoplasmic vacuol... | |||
T12365 | PARP/PI3K-IN-1 | PARP , PI3K | |
PARP/PI3K-IN-1 is a novel dual poly (ADP-ribose) polymerase (PARP) and phosphatidylinositol 3-kinase (PI3K) dual inhibitor with anticancer, antitumour and antiproliferative activities for the study of breast, pancreatic ... | |||
T5335 | S-Gboxin | Others | |
S-Gboxin is an active analogue of Gboxin with potent antitumour activity. S-Gboxin inhibits the growth of mouse and human glioblastoma (GBM, IC50: 470 nM). | |||
T5448 | Clanfenur | Others | |
Clanfenur belongs to a new group of substituted benzoylphenylureas. The drug shows both in vitro and in vivo antitumour activity. | |||
T15373 | Gboxin | ATPase , Mitochondrial Metabolism | |
Gboxin is an inhibitor of oxidative phosphorylation that targets glioblastoma,inhibits the activity of F0F1 ATP synthase, with antitumour activity. | |||
T71553 | Ainsliadimer A | ||
Ainsliadimer A, a sesquiterpene lactone dimer from Ainsliaea macrocephala, has antitumour activity and induces cell death in various cancer cells. | |||
T29857 | Alethine | β-Alethine | TNF |
Alethine (β-Alethine) is a small molecule compound with antitumour activity and is used to treat tumours and infections. The alethine-induced up-regulation of TNFα increases the cytotoxicity of T cells. | |||
T29541 | AC265347 | AC-265347 | CaSR |
AC265347 is a potent calcium-sensitive receptor (CaSR) agonist and ago-PAM orthosteric modulator with antitumour activity that inhibits neuroblastoma tumour growth by inducing differentiation.AC265347 can be used to stud... | |||
T11745 | KB SRC 4 | Src | |
KB SRC 4 is a selective and potent c-Src inhibitor with antitumour activity that inhibits the growth of cancer cells. | |||
T28284 | P22074 | P-22074 | DUB |
P22074 is a USP7 inhibitor. It is not an active antagonist like its halogenated related compounds. p22074 has antitumour activity. | |||
T69691 | Pocenbrodib | FT-7051,P-300 | Epigenetic Reader Domain |
Pocenbrodib (FT-7051) is a potent inhibitor of the bromodomain of the CBP/p300 family with potential antitumour activity and is palatable for cancer research. | |||
T77519 | FC-116 | FC116 | Apoptosis , Microtubule Associated |
FC-116 is a potent Tubulin inhibitor with antitumour activity and inhibits tumour growth in mice. FC-116 induces apoptosis in colorectal cancer (CRC) cells and promotes protein degradation. | |||
T26897 | BRD2492 | HDAC | |
BRD2492 is a selective and potent dual inhibitor of HDAC1 and HDAC2 with potential anticancer, antitumour and antiproliferative activities, inhibiting HDAC1/2, HDAC3 and HDAC6.BRD2492 inhibits the growth of breast cancer... | |||
T77810 | XPW1 | CDK | |
XPW1 is a new potent and selective CDK9 inhibitor with antitumour activity that transcriptionally inhibits the DNA repair process in ccRCC cells.XPW1 can be used to study clear cell renal cell carcinoma. | |||
T16697 | Pyronaridine tetraphosphate | Topoisomerase | |
Pyronaridine tetraphosphate is an orally active, mannitol-containing inhibitor of DNA topoisomerase 2 and erythrocyte cytokine with antimalarial and antitumour activity.Pyronaridine tetraphosphate treats P. falciparum an... | |||
T36646 | Trastuzumab deruxtecan | DS-8201a,VRN-101099,DS 8201,T-DXd | Others |
Trastuzumab deruxtecan (T-DXd) is an antibody-activated molecule coupling (ADC) with anticancer and antitumour activity.Trastuzumab deruxtecan has been shown to have an ameliorative effect in HER2-positive breast and gas... | |||
T63732 | EGFR-IN-3 | Apoptosis , EGFR | |
EGFR-IN-3 is an EGFR inhibitor with potential antitumour activity.EGFR-IN-3 inhibits EGFRwt-TK and induces apoptosis (cell death), which can cause cells to block in the G2/M phase. | |||
T67970 | GPX-100 | 13-deoxydoxorubicin | Others |
GPX-100 (13-deoxydoxorubicin) is an analogue of the anthracycline antitumour antibiotic doxorubicin. GPX-100 inserts into DNA and interacts with topoisomerase II to inhibit DNA replication and repair as well as RNA and p... | |||
T77759 | GPX4-IN-6 | GPX | |
GPX4-IN-6 is a small molecule covalent GPX4 inhibitor (IC50: 0.12 μM) with antitumour activity.GPX4-IN-6 induces iron death and is used for the treatment= and prevention of triple negative breast cancer (TNBC). | |||
T77755 | GPX4-IN-5 | GPX | |
GPX4-IN-5 is a small molecule covalent GPX4 inhibitor (IC50: 0.12 μM) with antitumour activity.GPX4-IN-5 induces iron death and can be used for the prevention and treatment of triple-negative breast cancer (TNBC). | |||
T72084 | (R)-BI-2852 | Ras | |
(R)-BI-2852 can be used as (R)-5-isoindolin-1-one is used as an inhibitor of the RAS family of proteins and as a compound for the treatment and prevention of tumours. (R)-BI-2852 has Antiproliferative and antitumour agen... | |||
T77745 | N6F11 | GPX | |
N6F11 is a novel, selective and potent inducer of iron death with anticancer and antitumour activity that promotes GPX4 degradation by binding to TRIM25 in cancer cells.N6F11 can be used to study pancreatic cancer. | |||
T15771 | Lobaplatin | D-19466 | DNA Alkylation |
Lobaplatin (D-19466) (D-19466) is a diastereometric mixture of platinum(II) complexe. Lobaplatin (D-19466) is a third-generation platinum anti-neoplastic agent which shows activity for a variety of tumour types and is a ... | |||
T72553 | ARTD10/PARP10-IN-1 | PARP | |
ARTD10/PARP10-IN-1 is a potent PARP inhibitor of the mono-ADP ribosyltransferases ARTD7/PARP15, ARTD8/PARP14, ARTD10/PARP10 and poly ADP-ribose polymerase-1 (ARTD1/PARP1), with potential anticancer and antitumour activit... | |||
T67934 | MRT-2359 | Others | |
MRT-2359 is a potent and orally available GSPT1 reducer with antitumour activity.MRT-2359 inhibits the growth of drug-resistant non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cells.MRT-2359 exhibits... | |||
T61338 | MS023 dihydrochloride | MS023 2HCl | Histone Methyltransferase |
MS023 dihydrochloride (MS023 2HCl) is a selective, cytosolic and highly potent inhibitor of human type I protein arginine methyltransferases (PRMTs) with antitumour activity, inhibits PRMT1, PRMT3, PRMT4, PRMT6, and PRMT... | |||
T60446 | LCS3 | Apoptosis , Glutathione reductase | |
LCS3 is a reversible and non-competitive synergistic inhibitor of glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) with IC50s of 3.3 μM and 3.8 μM, respectively. LCS3 has antitumour activity, in... | |||
T72505 | CTP Synthetase-IN-1 | Others | |
CTP Synthetase-IN-1 is an orally active and potent cytidine 5'-triphosphate synthetase (CTPS) inhibitor with potential antitumour activity, shows anti-inflammatory activity in animal models of inflammation, inhibits huma... | |||
T36082 | Cysmethynil | Autophagy , Ras | |
Cysmethynil is an indole-based time-dependent inhibitor of Icmt with antitumour activity and inhibitory effects on RAS membrane-binding and EGF signalling.Cysmethynil induces cell cycle arrest in G1 phase and induces cel... | |||
T4374 | Edoxudine | Aedurid,EUDR,Epoxudine | Antiviral , Antibacterial |
Edoxudine (Epoxudine), an antiviral drug, is an analogue of thymidine and shows effectiveness against the herpes simplex virus. Edoxudine is used as a 5-fluorouracil (FU) modulator. Edoxudine may be used to enhance the t... | |||
T63746 | Vamotinib | PF-114 | Apoptosis , Tyrosine Kinases , Bcr-Abl |
Vamotinib (PF-114) is an orally active and specific tyrosine kinase inhibitor with antiproliferative and antitumour activity.Vamotinib inhibits the phosphorylation of BCR/ABL and BCR/ABL-T315I, which promotes apoptosis. ... | |||
T62083 | Camonsertib | ATR inhibitor 4,RP-3500 | ATM/ATR |
Camonsertib (RP-3500) is a selective, orally active ATR kinase inhibitor (ATRi) with an IC50: 1.00 nM in biochemical assays and exhibits potent antitumour effects. Camonsertib is 30 times more selective for ATR than mTOR... | |||
T14680 | BMS-906024 | Osugacestat,AL-101,BM-0018 | Gamma-secretase |
BMS-906024 (Osugacestat) is an orally available and selective inhibitor of γ-secretase, a small molecule Notch inhibitor.BMS-906024 has broad-spectrum antitumour activity against a variety of human cancer xenografts.BMS-... | |||
T63049 | CHD1Li 6.11 | Others | |
CHD1Li 6.11 is a potent inhibitor of oncogenic CHD1L, acting on the cat-CHD1L recombinant protein (IC50: 3.3 μM). CHD1Li 6.11 is an orally active antitumour agent that significantly reduces the tumour volume of CRC xenog... | |||
T79745 | IDH2R140Q-IN-2 | Dehydrogenase | |
IDH2R140Q-IN-2 is an orally active and potent IDH2R140Q inhibitor with an IC50 of 29 nM.IDH2R140Q-IN-2 possesses potential antitumour activity, reducing D2HG production in TF-1 cell lines carrying the IDH2R140Q mutation ... | |||
T10870L | CP-547632 | VEGFR , FGFR , PDGFR , BTK | |
T62245 | Basroparib | ||
Basroparib is an inhibitor of ribose polymerase (PARP) and has shown antitumour effects. | |||
T62493 | QW30 | ||
QW30 has a significant antitumour effect (IC50: 0.33 μM). | |||
T62650 | Culmerciclib | ||
Culmerciclib is a cell cycle protein-dependent kinase (CDK) inhibitor that exhibits antitumour effects. | |||
T63084 | Guraxetan | ||
Guraxetan can be used in the synthesis of the antitumour drug Lutetium (177Lu) zadavotide Guraxetan. | |||
T64236 | AS 1411 | ||
AS1411 is a nucleic acid aptamer that targets nucleophosmin and exhibits antitumour effects. | |||
T64039 | KRAS G12C inhibitor 49 | ||
KRAS G12C inhibitor 49 is an orally active KRAS G12C inhibitor that exhibits antitumour effects. | |||
T63100 | EP4 receptor antagonist 2 | ||
EP4 receptor antagonist 2 (compound 2-13) is a potent agonist of the EP4 receptor (IC50: 7.8 nM) and has antitumour effects. |
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T1181 | Gefitinib | ZD1839 | EGFR , Tyrosine Kinases , Autophagy |
Gefitinib (ZD1839) is an EGFR first-generation inhibitor with oral activity that inhibits the EGFR 19 Del and L858R mutations. Gefitinib has antitumor activity and is used for the treatment of EGFR-mutated non-small-cell... | |||
Fr12290 | 4-Methoxycoumarine | Others | |
4-Methoxycoumarine has antitumour effects. | |||
TN1757 | Hypophyllanthin | Potassium Channel , Calcium Channel , P-gp | |
Hypophyllanthin and phyllanthin have antitumour effects against Ehrlich Ascites Carcinoma in mice. | |||
T7468 | (-)-α-Terpineol | α-Terpineol | Others |
(-)-α-Terpineol has antitumour, anti-inflammatory, and antimicrobial activities, it inhibits the growth of tumour cells through a mechanism that involves inhibition of the NF-kappaB pathway | |||
TMA2253 | Triumbelletin | Others | |
Triumbelletin is a tricoumarin rhamnopyranoside obtained from Wikstroemia indica with antitumour activity for the study of tumours. | |||
T5S1952 | 9-Methoxycamptothecin | Apoptosis , Topoisomerase | |
9-Methoxycamptothecin (MCPT) has antitumour activities through topoisomerase inhibition. | |||
T3S1858 | Lutein | Vegetable Lutein,Xanthophyll,Bo-Xan,Xantofyl | Antibacterial |
1. Lutein (Xantofyl) has antitumour action. 2. Lutein has antimutagenic action. 3. Lutein has a wide range of antimicrobial action. 4. Lutein is potentially useful for treating macular degeneration. | |||
T5S2083 | Puerarin 6''-O-Xyloside | Apoptosis , Caspase | |
Puerarin 6''-O-xyloside possesses significant anti-osteoporotic activity on ovariectomy mice, it has significant antitumour activities, the mechanisms are related to increased levels of caspase-3, caspase-7, caspase-9 an... | |||
T36914 | 2-Hydroxyanthraquinone | Others | |
2-Hydroxyanthraquinone is an anthraquinone that has been found inSpermacoce latifoliaand has antibacterial and estrogenic activities.1,2It is active againstB. subtilisandB. cereus(MICs = 1.9 and 62.5 μg/ml, respectively)... | |||
TN1664 | Ganoderic acid H | NF-κB , DNA/RNA Synthesis , CDK | |
Ganoderic acid H is a potent antitumour agent, it mediates its biological effects through the inhibition of transcription factors AP-1 and NF-kappaB, resulting in the down-regulation of expression of Cdk4. | |||
T3864 | Erianin | BCL , Antibacterial | |
Erianin is a nature product extracted from Dendrobium chrysotoxum, has notable antitumour activity , can cause extensive tumour necrosis, growth delay. Erianin has antiangiogenic action by inhibiting endothelial metaboli... | |||
T4001 | Euxanthone | 1,7-Dihydroxyxanthone | Autophagy |
Euxanthone (1,7-Dihydroxyxanthone), an xanthone derivative extracted from the roots of Polygala tenuifolia Willd, has antitumour, neuroprotective and vasorelaxant activities, and attenuates Aβ1-42-induced oxidative stres... | |||
T16165 | Myriocin | ISP-I,Thermozymocidin | HCV Protease , Antifungal |
Myriocin (Thermozymocidin), a metabolite derived from Myriococcum albomyces, is a serine-palmitoyltransferase (SPT) inhibitor with potential antitumour, anticancer, and antiparasitic activities.Myriocin inhibits tumour g... | |||
T4672 | Brevilin A | Apoptosis , Anti-infection , JAK , STAT , Autophagy | |
Brevilin A is a sesquiterpene lactone isolated from Centipeda minima, inhibits janus kinase activity and blocks STAT3 signaling in cancer cells with anti-tumor activity. Brevilin A is a selective inhibitor of JAK-STAT si... | |||
T3795 | Corilagin | Apoptosis , TLR , Reverse Transcriptase , Antibacterial , Autophagy | |
Corilagin has anti-inflammatory activity. Corilagin has a significant antitumour potential and lower toxicity in normal cells in vitro.Corilagin can enhance the cytotoxicity of both cisplatin and doxorubicin on the Hep3B... | |||
TN6043 | Cyclo(D-Leu-L-Pro) | ||
Cyclo(D-Leu-L-Pro) shows antitumour and antifungal activities. | |||
TN6569 | Cis-Moschamine | ||
cis-Moschamine exerts antitumour effects on HeLa, MCF7 and A431 cells. | |||
T28920 | TAN-420C | TAN 420C,TAN420C,Dihydroherbimycin C | |
TAN-420C is an antibiotic isolated from Streptomyces hygroscopicus with antitumour activity. | |||
TN2002 | Obovatol | BCL , Caspase , JAK | |
Obovatol has antioxidant, neuroprotective, antiinflammatory, antithrombotic and antitumour effects, it is a potent NF-κB inhibitors for Alzheimer's disease treatment. | |||
TN5021 | Sikokianin C | ||
Sikokianin C is a biflavonoid isolated from Wikstroemia sikokiana.Sikokianin C is a selective cystathionine β-synthase inhibitor with antitumour activity for the treatment of human colon cancer. | |||
TN2328 | Zeylenone | Apoptosis , ERK , MAPK , Akt , PI3K , mTOR | |
Zeylenone, a cyclohexene oxide from Uvaria grandiflora, has antitumour and antiproliferative activity, inhibiting cervical cancer cell proliferation and inducing apoptosis through the PI3K/AKT/mTOR and MAPK/ERK signallin... | |||
TN2344 | Swainsonine | Tridolgosir | Apoptosis , Others , Antibiotic |
Swainsonine (Tridolgosir) is an alkaloid isolated from Astragalus membranaceus and is a potent and reversible inhibitor of alpha-mannosidase. swainsonine has antitumour activity and induces apoptosis and cell cycle arres... |